Literature DB >> 16972887

Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas.

B Birlik1, S Canda, E Ozer.   

Abstract

Astrocytomas are the commonest type of brain tumours in adults and children. Although the most reliable prognostic indicators have been shown consistently to be patient age and tumour histological grade, biological progression in these tumours is inevitable and the overall prognosis has remained poor. Due to the evidence that vascular changes are important histological features of astrocytomas, the aim of this study was to investigate prognostic significance of tumour vascularity in paediatric and adult astrocytomas. Study population consisted of 70 patients (45 adult and 25 children) with histologically proven diagnosis of astrocytoma with no history of previous therapy. Histological quantification of tumour vascularity was performed using three different methods: microvessel density, vascular grading and Chalkley counting. Histological classification and grading were also assessed using the World Health Organization system. In contrast to the results in paediatric astrocytomas, tumour vascularity in adult tumours correlated significantly with postoperative survival by univariate analysis (P < 0.05). Microvessel density appeared to be an independent indicator of prognosis by multivariate analysis (P = 0.001). Likewise, patients with microvessel density of 70 or greater had significantly shorter survival than the remaining group (P < 0.001). Patient age and tumour histological grade were also correlated with survival. We conclude that histological quantification of tumour vascularity is a significant prognosticator in adult astrocytomas, but not in children. Our data do not support the validity of applications of antiangiogenic agents in paediatric astrocytic tumours, particularly pilocytic astrocytomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16972887     DOI: 10.1111/j.1365-2990.2006.00763.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  22 in total

1.  High accuracy of arterial spin labeling perfusion imaging in differentiation of pilomyxoid from pilocytic astrocytoma.

Authors:  S A Nabavizadeh; R Assadsangabi; M Hajmomenian; M Santi; A Vossough
Journal:  Neuroradiology       Date:  2015-02-10       Impact factor: 2.804

2.  Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors.

Authors:  Itzik Cooper; David Last; David Guez; Shirley Sharabi; Shirin Elhaik Goldman; Irit Lubitz; Dianne Daniels; Sharona Salomon; Gregory Tamar; Tzur Tamir; Ronni Mardor; Mati Fridkin; Yoram Shechter; Yael Mardor
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-11       Impact factor: 6.200

3.  Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma.

Authors:  Shi-Yong Wang; Yi-Quan Ke; Guo-Hui Lu; Zhen-Hua Song; Li Yu; Sha Xiao; Xin-Lin Sun; Xiao-Dan Jiang; Zhi-Lin Yang; Chang-Chen Hu
Journal:  J Neurooncol       Date:  2013-02-16       Impact factor: 4.130

4.  Evaluation of Endoglin as an Angiogenesis Marker in Glioblastoma.

Authors:  Noushin Afshar Moghaddam; Parvin Mahsuni; Diana Taheri
Journal:  Iran J Pathol       Date:  2015

Review 5.  Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors.

Authors:  Woo-Young Kim; Ho-Young Lee
Journal:  FEBS J       Date:  2009-07-31       Impact factor: 5.542

6.  MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop.

Authors:  Lili Jiang; Chuyong Lin; Libing Song; Jueheng Wu; Baixue Chen; Zhe Ying; Lishan Fang; Xiao Yan; Mian He; Jun Li; Mengfeng Li
Journal:  J Clin Invest       Date:  2011-12-12       Impact factor: 14.808

7.  Arterial spin-labeled perfusion of pediatric brain tumors.

Authors:  K W Yeom; L A Mitchell; R M Lober; P D Barnes; H Vogel; P G Fisher; M S Edwards
Journal:  AJNR Am J Neuroradiol       Date:  2013-08-01       Impact factor: 3.825

8.  Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.

Authors:  Manuel Nieto-Sampedro; Beatriz Valle-Argos; Diego Gómez-Nicola; Alfonso Fernández-Mayoralas; Manuel Nieto-Díaz
Journal:  Clin Med Insights Oncol       Date:  2011-09-21

Review 9.  The functional role of Notch signaling in human gliomas.

Authors:  Marie-Thérése Stockhausen; Karina Kristoffersen; Hans Skovgaard Poulsen
Journal:  Neuro Oncol       Date:  2009-12-14       Impact factor: 12.300

Review 10.  Passive immunotherapeutic strategies for the treatment of malignant gliomas.

Authors:  Daniel T Nagasawa; Christina Fong; Andrew Yew; Marko Spasic; Heather M Garcia; Carol A Kruse; Isaac Yang
Journal:  Neurosurg Clin N Am       Date:  2012-07       Impact factor: 2.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.